Insider Profile
Noble, Craig
2
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Sep 15, 2023
Most Recent Trade
34
Credibility
Score
61%
Hit Rate
-1.2%
Avg 90d Return
+2.9%
Median 90d Return
23
Evaluated Trades
+13.8%
Best Trade
-26.9%
Worst Trade
Hit rate and returns are based on 23 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
across 2 issuers · entity-resolved
50%
Hit Rate · 90d
+6.4%
Median Alpha · 90d
6
Closed Buys Evaluated
67%
Beat XIU
2
Issuers Traded
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency multi issuer
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 6 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Sep 15, 2023 $BAM
Brookfield Asset Management
— Exercise Sell 150,000 $14.77 $2.2M 58
Sep 15, 2023 $BAM
Brookfield Asset Management
— Exercise Sell 19,687 $17.54 $345K 58
Sep 15, 2023 $BAM
Brookfield Asset Management
— Open Market Buy 169,687 $35.82 $6.1M 58
Sep 15, 2023 $BAM
Brookfield Asset Management
— Exercise Buy 150,000 $14.77 $2.2M 58
Sep 15, 2023 $BAM
Brookfield Asset Management
— Exercise Buy 19,687 $17.54 $345K 58
Sep 15, 2023 $BN
Brookfield Corporation
— Exercise Sell 300,000 $16.70 $5.0M 58
Sep 15, 2023 $BN
Brookfield Corporation
— Exercise Sell 78,750 $19.83 $1.6M 58
Sep 15, 2023 $BN
Brookfield Corporation
— Open Market Buy 378,750 $36.10 $13.7M 58
Sep 15, 2023 $BN
Brookfield Corporation
— Exercise Buy 300,000 $16.70 $5.0M 58
Sep 15, 2023 $BN
Brookfield Corporation
— Exercise Buy 78,750 $19.83 $1.6M 58
May 09, 2023 $BN
Brookfield Corporation
— Plan / DRIP Buy 2,442 — — 58
Sep 30, 2022 $BN
Brookfield Corporation
— Ownership Chg Buy 41,233 — — 58
Sep 30, 2022 $BN
Brookfield Corporation
— Comp. Grant Buy 890,234 $43.92 $39.1M 58
Sep 30, 2022 $BN
Brookfield Corporation
— Ownership Chg Sell 41,233 — — 58
Sep 23, 2022 $BN
Brookfield Corporation
— Exercise Buy 109,766 $43.92 $4.8M 58
Sep 23, 2022 $BN
Brookfield Corporation
— Exercise Sell 1,000,000 $43.92 $43.9M 58
May 09, 2022 $BN
Brookfield Corporation
— Other Sell 5,644 — — 58
May 09, 2022 $BN
Brookfield Corporation
— Plan / DRIP Buy 1,733 — — 58
May 09, 2022 $BN
Brookfield Corporation
— Other Buy 8 — — 58
Feb 18, 2022 $BN
Brookfield Corporation
— Other Buy 250,000 $56.93 $14.2M 58
May 28, 2020 $BN
Brookfield Corporation
— Exercise Sell 7,506 — — 58
May 28, 2020 $BN
Brookfield Corporation
— Open Market Buy 7,506 $29.91 $225K 58
May 28, 2020 $BN
Brookfield Corporation
— Exercise Buy 7,506 — — 58
May 20, 2020 $BN
Brookfield Corporation
— Plan / DRIP Buy 1,747 — — 58
Apr 01, 2020 $BN
Brookfield Corporation
— Corp. Event Buy 1,194 — — 58
Apr 01, 2020 $BN
Brookfield Corporation
— Corp. Event Buy 25,110 — — 58
Apr 01, 2020 $BN
Brookfield Corporation
— Corp. Event Buy 946,250 — — 58
Apr 01, 2020 $BN
Brookfield Corporation
— Corp. Event Buy 59,163 — — 58
Apr 01, 2020 $BN
Brookfield Corporation
— Corp. Event Buy 250,000 — — 58
Feb 24, 2020 $BN
Brookfield Corporation
— Exercise Sell 1,586 — — 58
Feb 24, 2020 $BN
Brookfield Corporation
— Open Market Buy 1,586 $65.64 $104K 58
Feb 24, 2020 $BN
Brookfield Corporation
— Exercise Buy 1,586 — — 58
Jan 02, 2020 $BN
Brookfield Corporation
— Open Market Buy 94,404 $57.70 $5.4M 58
Jan 02, 2020 $BN
Brookfield Corporation
— Open Market Buy 16,196 $57.85 $937K 58
Jan 02, 2020 $BN
Brookfield Corporation
— Exercise Sell 225,000 $26.77 $6.0M 58
Jan 02, 2020 $BN
Brookfield Corporation
— Exercise Sell 210,000 $36.32 $7.6M 58
Jan 02, 2020 $BN
Brookfield Corporation
— Exercise Buy 110,600 $57.80 $6.4M 58
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.